Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV

Virology

Volumn 405, Issue 1, 2010, Pages 225-233

  Caron, Mélanie ^a   Besson, Guillaume ^a   Etenna, Sonia Lekana Douki ^a   Mintsa Ndong, Armel ^a   Mourtas, Spyridon ^b   Radaelli, Antonia ^c   Morghen, Carlo De Giuli ^c   Loddo, Roberta ^d   La Colla, Paolo ^d   Antimisiaris, Sophia G ^b,e   Kazanji, Mirdad ^a,f  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

^f INSTITUT PASTEUR   (France)

Author keywords

Liposomal gel; MC1220; Microbicide; Protection; Proviral load; RT SHIV; T cell subset; Viral load

Indexed keywords

IMMUNOGLOBULIN; LIPOSOME; MC 1220; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUTOPSY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE SUBPOPULATION; VAGINA; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77955510139     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.008     Document Type: Article

References (38)

1. Abdool Karim S.S. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials. Future Microbiol. 2010, 5(4):527-529.
2. Ambrose Z., Palmer S., Boltz V.F., Kearney M., Larsen K., Polacino P., Flanary L., Oswald K., Piatak M., Smedley J., Shao W., Bischofberger N., Maldarelli F., Kimata J.T., Mellors J.W., Hu S.L., Coffin J.M., Lifson J.D., KewalRamani V.N. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J. Virol. 2007, 81(22):12145-12155.
3. Cranage M., Sharpe S., Herrera C., Cope A., Dennis M., Berry N., Ham C., Heeney J., Rezk N., Kashuba A., Anton P., McGowan I., Shattock R. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med. 2008, 5(8):e157. discussion e157.
4. D'Cruz O.J., Uckun F.M. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. J. Antimicrob. Chemother. 2006, 57(3):411-423.
5. D'Cruz O.J., Samuel P., Waurzyniak B., Uckun F.M. Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide. Biol. Reprod. 2003, 69(6):1843-1851.
6. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 2000, 74(18):8358-8367.
7. Duerr A., Wasserheit J.N., Corey L. HIV vaccines: new frontiers in vaccine development. Clin. Infect. Dis. 2006, 43(4):500-511.
8. Galvin S.R., Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2004, 2(1):33-42.
9. Garcia-Lerma J.G., Otten R.A., Qari S.H., Jackson E., Cong M.E., Masciotra S., Luo W., Kim C., Adams D.R., Monsour M., Lipscomb J., Johnson J.A., Delinsky D., Schinazi R.F., Janssen R., Folks T.M., Heneine W. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med. 2008, 5(2):e28.
10. Harouse J.M., Gettie A., Eshetu T., Tan R.C., Bohm R., Blanchard J., Baskin G., Cheng-Mayer C. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J. Virol. 2001, 75(4):1990-1995.
11. Hofmann-Lehmann R., Williams A.L., Swenerton R.K., Li P.L., Rasmussen R.A., Chenine A.L., McClure H.M., Ruprecht R.M. Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection. AIDS Res. Hum. Retroviruses 2002, 18(9):627-639.
12. Hossain M.M., Parniak M.A. In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1. J. Virol. 2006, 80(9):4440-4446.
13. Hu Q., Frank I., Williams V., Santos J.J., Watts P., Griffin G.E., Moore J.P., Pope M., Shattock R.J. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 2004, 199(8):1065-1075.
14. Jiang Y.H., Emau P., Cairns J.S., Flanary L., Morton W.R., McCarthy T.D., Tsai C.C. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses 2005, 21(3):207-213.
15. Kilby J.M., Hopkins S., Venetta T.M., DiMassimo B., Cloud G.A., Lee J.Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M.R., Nowak M.A., Shaw G.M., Saag M.S. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 1998, 4(11):1302-1307.
16. Klausner R.D., Fauci A.S., Corey L., Nabel G.J., Gayle H., Berkley S., Haynes B.F., Baltimore D., Collins C., Douglas R.G., Esparza J., Francis D.P., Ganguly N.K., Gerberding J.L., Johnston M.I., Kazatchkine M.D., McMichael A.J., Makgoba M.W., Pantaleo G., Piot P., Shao Y., Tramont E., Varmus H., Wasserheit J.N. Medicine. The need for a global HIV vaccine enterprise. Science 2003, 300(5628):2036-2039.
17. Kreiss J., Ngugi E., Holmes K., Ndinya-Achola J., Waiyaki P., Roberts P.L., Ruminjo I., Sajabi R., Kimata J., Fleming T.R., et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. Jama 1992, 268(4):477-482.
18. Lederman M.M., Veazey R.S., Offord R., Mosier D.E., Dufour J., Mefford M., Piatak M., Lifson J.D., Salkowitz J.R., Rodriguez B., Blauvelt A., Hartley O. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 2004, 306(5695):485-487.
19. Loftsson T., Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 2001, 225(1-2):15-30.
20. Marx P.A., Spira A.I., Gettie A., Dailey P.J., Veazey R.S., Lackner A.A., Mahoney C.J., Miller C.J., Claypool L.E., Ho D.D., Alexander N.J. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 1996, 2(10):1084-1089.
21. McGowan I. Microbicides: a new frontier in HIV prevention. Biologicals 2006, 34(4):241-255.
22. Munch J., Rajan D., Schindler M., Specht A., Rucker E., Novembre F.J., Nerrienet E., Muller-Trutwin M.C., Peeters M., Hahn B.H., Kirchhoff F. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J. Virol. 2007, 81(24):13852-13864.
23. Mourtas G., Fotopoulou S., Duraj S., Sfika V., Tsakiroglou C., Antimisiaris S.G. Liposomal drugs dispersed in hydrogels: effect of liposome, drug and gel properties on drug release kinetics. Colloids Surfaces B Biointerfaces 2007, 55(2):212-221.
24. Pani A., Musiu C., Loi A.G., Mai A., Loddo R., La Colla P., Marongiu M.E. DABOs as candidates to prevent mucosal HIV transmission. Antivir. Chem. Chemother. 2001, 12(Suppl 1):51-59.
25. Roddy R.E., Zekeng L., Ryan K.A., Tamoufe U., Weir S.S., Wong E.L. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J. Med. 1998, 339(8):504-510.
26. Schols D. HIV co-receptors as targets for antiviral therapy. Curr. Top. Med. Chem. 2004, 4(9):883-893.
27. Shattock R.J., Moore J.P. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 2003, 1(1):25-34.
28. Skoler-Karpoff S., Ramjee G., Ahmed K., Altini L., Plagianos M.G., Friedland B., Govender S., De Kock A., Cassim N., Palanee T., Dozier G., Maguire R., Lahteenmaki P. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9654):1977-1987.
29. Stahl-Hennig C., Dittmer U., Nisslein T., Petry H., Jurkiewicz E., Fuchs D., Wachter H., Matz-Rensing K., Kuhn E.M., Kaup F.J., Rud E.W., Hunsmann G. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J. Gen. Virol. 1996, 77(Pt 12):2969-2981.
30. Stewart J.C. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 1980, 104(1):10-14.
31. Stolte-Leeb N., Bieler K., Kostler J., Heeney J., Haaft P.T., Suh Y.S., Hunsmann G., Stahl-Hennig C., Wagner R. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone. Viral Immunol. 2008, 21(2):235-246.
32. Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 2002, 1(12):977-985.
33. Teleshova N., Chang T., Profy A., Klotman M.E. Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer. Antimicrob. Agents Chemother. 2008, 52(5):1751-1758.
34. Uberla K., Stahl-Hennig C., Bottiger D., Matz-Rensing K., Kaup F.J., Li J., Haseltine W.A., Fleckenstein B., Hunsmann G., Oberg B., et al. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A 1995, 92(18):8210-8214.
35. Van Herrewege Y., Michiels J., Van Roey J., Fransen K., Kestens L., Balzarini J., Lewi P., Vanham G., Janssen P. In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrob. Agents Chemother. 2004, 48(1):337-339.
36. Van Herrewege Y., Vanham G., Michiels J., Fransen K., Kestens L., Andries K., Janssen P., Lewi P. A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides. Antimicrob. Agents Chemother. 2004, 48(10):3684-3689.
37. Veazey R.S., Shattock R.J., Pope M., Kirijan J.C., Jones J., Hu Q., Ketas T., Marx P.A., Klasse P.J., Burton D.R., Moore J.P. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 2003, 9(3):343-346.
38. Veazey R.S., Klasse P.J., Schader S.M., Hu Q., Ketas T.J., Lu M., Marx P.A., Dufour J., Colonno R.J., Shattock R.J., Springer M.S., Moore J.P. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 2005, 438(7064):99-102.